NIH Reporter #5R01DA062274-02

Research Grant Solicitation: Neuroinflammation in HIV, Cocaine, and cART Context

This opportunity is a research grant solicitation from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, focused on neuroinflammation in the context of HIV, cocaine, and antiretroviral therapy (cART). - Government Buyer: - National Institute on Drug Abuse (NIDA), National Institutes of Health - Products/Services Requested: - One research project investigating the molecular interplay of HIV Tat, cocaine, and cART in microglial pyroptosis - Emphasis on the role of the NLRP3 inflammasome - OEMs and Vendors: - No specific OEMs or vendors are named in the solicitation - Unique or Notable Requirements: - Expertise required in neuroinflammation, HIV research, and related biomedical fields - Project classified under Public Health, Related Programs - Lump sum award for a single research project - Applicants should review the Funding Opportunity Announcement (FOA) for detailed requirements

Description

This is a research grant opportunity focused on studying the molecular interactions of HIV Tat, cocaine, and combination antiretroviral therapy (cART) in microglial pyroptosis, specifically the role of the NLRP3 inflammasome. The project is aimed at understanding neuroinflammation related to these factors. The solicitation is open for bids and prospective bidders should review the Funding Opportunity Announcement (FOA) to prepare their proposals accordingly.

View original listing